EMAGIX DIAGNOSTICS
Branding and graphic design for international medical research company

The Challenge
Client: Emagix Diagnostics
Location: Halifax, Nova Scotia
Services: Corporate Branding, Logo Design, Product Branding, Logo Design, Investor Relations Proposals, Interface Design
Halifax-based medical research company Emagix Diagnostics specializes in breakthrough software algorithms that analyze cerebral hemodynamics and blood flow dynamics in the human brain. Compatible with standard hospital imaging modalities like X-rays and CT scans, the platform delivers objective assessments that detect early microvascular hemorrhages and pinpoint compromised vessels—giving clinicians critical data to intervene early and mitigate long-term brain injury. To secure institutional funding and communicate their diagnostic capabilities to global medical networks, Emagix required an integrated brand ecosystem, product branding for their AI suite, intuitive interface layouts, and comprehensive investor presentation materials.
The Visual Concept & Biological Symbiosis
The identity balances cutting-edge data science with biological humanity through deliberate organic and geometric metaphors.
The Cerebral Tree of Life: The corporate mark synthesizes the silhouette of the human brain with the branching structure of a tree. The branches mirror both neural pathways and complex microvascular networks, representing life, cognitive resilience, and precise hemodynamic mapping.
RetiCAD™ AI Product Brand
Designed a specialized product identity for RetiCAD—an AI-driven platform for diabetic retinopathy detection—incorporating a calibrated bullseye reticle to represent focused algorithmic scanning of retinal vessels.
Clinical Color & Urgency: Striking arterial red linework paired with clean technical grays communicates diagnostic precision, circulatory dynamics, and the critical window for early intervention.
Interface & Infographic Architecture: Clean digital UI schematics and technical infographics illustrating complex biological mechanisms, traumatic brain injury pathways, and diagnostic software workflows.
Deliverables & Brand Impact
Corporate & Sub-Brand Identity: Scalable vector brand marks for Emagix Diagnostics and the RetiCAD product platform, engineered for medical journals, hardware integration, and digital portals.
Investor Relations Presentation Suite: High-impact proposal decks and technical visualizations showcasing clinical trial data, market opportunity, and software efficacy for venture capital partners.
Diagnostic Software Interface Design: Intuitive UI wireframes and visual design systems for clinical data dashboards and imaging analysis tools.
Scientific Graphic Assets: Custom biological illustrations detailing microvascular hemorrhaging, cellular degradation, and therapeutic intervention timelines.






